Michael Andrew Chambers serves as Executive at Sarepta Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Michael Andrew Chambers has executed 17 insider transactions totaling $23.3M, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 16, 2024 involved purchasing 13,106 shares valued at $1.7M.
Michael Andrew Chambers currently holds 260,102 shares of Sarepta Therapeutics, Inc. (SRPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Andrew Chambers has been a net buyer of SRPT stock. They have purchased $23.3M and sold $0 worth of shares.
Michael Andrew Chambers's most recent insider trade was on Aug 16, 2024, when they purchased 13,106 shares at $133.07 per share.
Get notified when new Form 4 filings are submitted
| $134.06 |
| Discretionary |
| Aug 16, 2024 | SRPT | $760.6K | Purchase | 5,648 | $134.66 | Discretionary |
| Mar 1, 2024 | SRPT | $0 | Award | 1,846 | $N/A | Discretionary |
| Aug 14, 2023 | SRPT | $649.4K | Purchase | 5,947 | $109.19 | Discretionary |
| Aug 14, 2023 | SRPT | $443.1K | Purchase | 4,032 | $109.89 | Discretionary |
| Aug 11, 2023 | SRPT | $2.6M | Purchase | 23,686 | $108.05 | Discretionary |
| Aug 10, 2023 | SRPT | $3.4M | Purchase | 31,570 | $106.26 | Discretionary |
| Aug 10, 2023 | SRPT | $115.5K | Purchase | 1,091 | $105.90 | Discretionary |
| Aug 10, 2023 | SRPT | $230.9K | Purchase | 2,206 | $104.67 | Discretionary |
| Mar 6, 2023 | SRPT | $0 | Award | 1,523 | $N/A | Discretionary |
| Sep 14, 2022 | SRPT | $657.3K | Purchase | 6,250 | $105.16 | Discretionary |
| Sep 14, 2022 | SRPT | $2.2M | Purchase | 20,744 | $103.87 | Discretionary |
| Sep 14, 2022 | SRPT | $3.2M | Purchase | 30,106 | $104.67 | Discretionary |
| Aug 19, 2022 | SRPT | $4.3M | Purchase | 40,110 | $108.20 | Discretionary |
| Aug 19, 2022 | SRPT | $659.3K | Purchase | 6,060 | $108.80 | Discretionary |
| Jun 2, 2022 | SRPT | $0 | Award | 4,908 | $N/A | Discretionary |